Management of the extrapyramidal manifestations of phenylketonuria with L-dopa.
D001480:Basal Ganglia Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007980:Levodopa / Q000627:therapeutic use*; D010661:Phenylketonurias / Q000150:complications*
D007980:Levodopa